Form 4: Phillip Frost Increases Stake in OPKO Health with $444,300 Purchase

Phillip Frost, CEO and Chairman of OPKO Health, along with Frost Gamma Investments Trust, reports purchasing 500,000 shares of OPKO Health common stock at an average price of $0.8886 on March 14, 2024.

Summary

• On March 14, 2024, Phillip Frost, CEO and Chairman of OPKO Health, acquired 500,000 shares of OPKO Health common stock.
• The shares were purchased at a weighted average price of $0.8886, with individual prices ranging from $0.8862 to $0.89.
• The total value of the purchase was approximately $444,300.
• Following the transaction, Dr. Frost directly owns 3,068,951 shares and indirectly owns 210,468,225 shares through Frost Gamma Investments Trust and 30,127,177 shares through Frost Nevada Investments Trust.
• Frost Gamma Investments Trust also reported its holdings as a 10% owner.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to insider buying, which often signals confidence in the company's prospects. However, it's just one transaction and needs to be considered alongside other factors.

Positives

• The CEO's purchase of shares may signal confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that those with the most knowledge of the company believe its stock is undervalued or that positive developments are on the horizon. However, it's important to consider the overall context of the company's performance and industry trends.

Stakeholder Impact

• Shareholders may view the insider purchase positively.
• The purchase could potentially increase investor confidence.

Key Dates